|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0205265,
umls-concept:C0332293,
umls-concept:C0392747,
umls-concept:C0871261,
umls-concept:C1554963,
umls-concept:C1555582,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1707520,
umls-concept:C1709305,
umls-concept:C2911692
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-4-19
|
|
pubmed:abstractText |
HVR-1 quasispecies composition and evolution were investigated in patients chronically infected with genotype 1b HCV, treated with PEG-IFN alpha 2b or STD-IFN alpha 2b plus RBV.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:AbbateIsabellaI,
pubmed-author:AntonucciGiorgioG,
pubmed-author:CapobianchiMaria RMR,
pubmed-author:CappielloGiuseppinaG,
pubmed-author:CraxìAntonioA,
pubmed-author:Di MarcoVitoV,
pubmed-author:Di StefanoRosaR,
pubmed-author:FerraroDonatellaD,
pubmed-author:GirardiEnricoE,
pubmed-author:IppolitoGiuseppeG,
pubmed-author:Lo IaconoOresteO,
pubmed-author:LongoRobertaR,
pubmed-author:SolmoneMariacarmelaM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
831-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15094232-Adult,
pubmed-meshheading:15094232-Antiviral Agents,
pubmed-meshheading:15094232-Drug Resistance, Viral,
pubmed-meshheading:15094232-Drug Therapy, Combination,
pubmed-meshheading:15094232-Evolution, Molecular,
pubmed-meshheading:15094232-Female,
pubmed-meshheading:15094232-Genetic Variation,
pubmed-meshheading:15094232-Hepacivirus,
pubmed-meshheading:15094232-Hepatitis C, Chronic,
pubmed-meshheading:15094232-Humans,
pubmed-meshheading:15094232-Interferon-alpha,
pubmed-meshheading:15094232-Male,
pubmed-meshheading:15094232-Middle Aged,
pubmed-meshheading:15094232-Phylogeny,
pubmed-meshheading:15094232-Polyethylene Glycols,
pubmed-meshheading:15094232-Prognosis,
pubmed-meshheading:15094232-Recombinant Proteins,
pubmed-meshheading:15094232-Ribavirin,
pubmed-meshheading:15094232-Viral Proteins
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin.
|
|
pubmed:affiliation |
Department of Virology, National Institute for Infectious Diseases L. Spallanzani, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
